This site is intended for health professionals only
Tuesday 21 August 2018
Share |

Topic: Microbiology

September 19, 2015
Urinary tract infections (UTIs) could be treated more quickly and efficiently using a DNA sequencing device the size of a USB stick – according to research from the University of East Anglia

Researchers used a new device called MinION to perform nanopore sequencing to characterise bacteria from urine samples four times more quickly than using traditional methods of culturing bacteria.

The new method can also detect antibiotic resistance – allowing patients to be treated more effectively and improving stewardship of diminishing antibiotic reserves.

May 11, 2015
This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks. Tuberculosis (TB) disease rates in some parts of London are as high as in Sub-Saharan Africa, and drug-resistant strains are becoming increasingly common. These require specific treatments, and if doctors know that a bug is resistant they can start therapy earlier, often leading to better outcomes.

This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks. Tuberculosis (TB) disease rates in some parts of London are as high as in Sub-Saharan Africa, and drug-resistant strains are becoming increasingly common. These require specific treatments, and if doctors know that a bug is resistant they can start therapy earlier, often leading to better outcomes.

April 29, 2015
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) announced breaking developments in the global fight against infections – with new mechanisms and approaches presented by smaller companies in a dedicated pipeline session at the annual congress (ECCMID) in Copenhagen.

The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) announced breaking developments in the global fight against infections – with new mechanisms and approaches presented by smaller companies in a dedicated pipeline session at the annual congress (ECCMID) in Copenhagen.
 
Ursula Theuretzbacher, the founder of the Centre for Anti-Infective Agents in Vienna, led the session, which gave a review of the research and development programmes from across some of the most innovative and nimble European biotech companies.

April 28, 2015
Leading chemical technology specialist, Accepta, has revealed its brand new, eco-friendly fogging system, which can be used for high-quality room disinfection and infection control cleaning in environments where protection against harmful bacteria and deadly viruses is required.

Leading chemical technology specialist, Accepta, has revealed its brand new, eco-friendly fogging system, which can be used for high-quality room disinfection and infection control cleaning in environments where protection against harmful bacteria and deadly viruses is required.

March 26, 2015
The Digital Pathology Centre of Excellence is jointly developed by the Trust, Coventry and Warwickshire Pathology services (CWPS), the University of Warwick, and Omnyx, LLC, a joint venture of GE Healthcare and UPMC (University of Pittsburgh Medical Center).

The Digital Pathology Centre of Excellence is jointly developed by the Trust, Coventry and Warwickshire Pathology services (CWPS), the University of Warwick, and Omnyx, LLC, a joint venture of GE Healthcare and UPMC (University of Pittsburgh Medical Center).
 
A year ago, the Trust, in conjunction with CWPS, became the first in the country to use software and digitised slides of tissues for clinical diagnosis, allowing pathologists to view samples in high resolution on their computer screens and from any location.
 

November 19, 2014
Clostridium difficile infection, a potentially fatal disease, is at least twice as common as MRSA infections in hospitals and is estimated to cost the EU €3 billion per annum.

Clostridium difficile infection, a potentially fatal disease, (2) is at least twice as common as MRSA infections in hospitals (3,4) and is estimated to cost the EU €3 billion per annum. (5)
 

October 23, 2014
The MicroSnap product range is simple rapid test for bacteria giving results in the same shift, and the range is extended to include Enterobacteriaceae. The measurement of Enterobacteriaceae is a useful indicator of surface hygiene and product quality in the manufacture of heat-processed food. Simple, rapid tests such as the specific ATP test system (MicroSnap EB) provides results in a working shift of <8 hours.

The MicroSnap product range is simple rapid test for bacteria giving results in the same shift, and the range is extended to include Enterobacteriaceae. The measurement of Enterobacteriaceae is a useful indicator of surface hygiene and product quality in the manufacture of heat-processed food. Simple, rapid tests such as the specific ATP test system (MicroSnap EB) provides results in a working shift of <8 hours.

October 31, 2012
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), has announced that it obtained CE Marking of the BD MAX™ Cdiff Assay. The assay detects the toxin B gene (tcdB), which has been shown to be present in all toxigenic C. difficile and is essential for disease.
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), has announced that it obtained CE Marking of the BD MAX™ Cdiff Assay. The assay detects the toxin B gene (tcdB), which has been shown to be present in all toxigenic C. difficile and is essential for disease.
 
Run on the fully automated BD MAX™ System, the assay is designed to rapidly and accurately identify patients with Clostridium difficile infection (CDI), including those caused by hypervirulent strains.
June 18, 2008
The UK's National Health Service has received thousands of "infection-resistant" keyboards

Britain's National Health Service (NHS) has received thousands of "infection-resistant" keyboards as part of a million pound contract to cut infection rates.

The Medigenic keyboards are completely flat and covered with a hypoallergenic material which is resistant to the growth of bacteria like Clostridium difficile and methicillin-resistant Staphylococcus aureus.

A timed light flashes on and off when the keyboard needs cleaning and also reminds staff to wash their hands.

June 18, 2008
Vaccine and public health experts will gather in Paris to review the latest research

Vaccine and public health experts will gather in Paris to review the promise of and challenges related to today's vaccine research, what new products are expected and to discuss the way forward.

The eighth World Health Organization Global Vaccine Research Forum will take place at the Institut Pasteur, Paris, France, from 29 June to 2 July.

About 150 top vaccine researchers, scientists and public health experts from around the world will participate. The Forum is sponsored by the WHO Initiative for Vaccine Research.

May 29, 2008
bioMérieux will unveil a new suite of “Full Microbiology Laboratory Automation” solutions

bioMérieux, an in vitro diagnostics company based in Paris, France, will unveil a new suite of "Full Microbiology Laboratory Automation" solutions at the 108th General Meeting of the American Society for Microbiology (ASM), held June 1-5 in Boston.

The products aim to streamline operations and make more reliable results available faster, particularly in light of the growing threat of healthcare-acquired infections, said the company.

May 29, 2008
bioMérieux will unveil a new suite of “Full Microbiology Laboratory Automation” solutions

bioMérieux, an in vitro diagnostics company based in Paris, France, will unveil a new suite of "Full Microbiology Laboratory Automation" solutions at the 108th General Meeting of the American Society for Microbiology (ASM), held June 1-5 in Boston.

The products aim to streamline operations and make more reliable results available faster, particularly in light of the growing threat of healthcare-acquired infections, said the company.

May 23, 2008
A UK hospital has installed a new system to supply HTM2030-compliant water

A UK hospital which is expanding its endoscope reprocessing department has installed a new system to supply HTM2030-compliant water.

Around 50 endoscopes are currently being reprocessed each day in the 450-bed Barnsley Hospital, by means of two Labcaire Guardian automatic reprocessors.

However, the capacity is set to increase by 50%, due to increasing demand not only from within the hospital but also from others in the area.

An ELGA Process Water Biopure 600 unit will be installed to meet this need.

May 6, 2008
A screening service designed for hospitals in the fight against “superbugs" has been launched

A screening service designed to help hospitals in the fight against "superbugs" such as methicillin-resistant Staphylococcus aureus (MRSA) has been launched in the UK.

Synergy Healthcare is aiming the service at hospitals, residential homes and care facilities through its pathology division JMJ laboratories. The system will screen people entering healthcare facilities for MRSA.

December 12, 2007
Antimicrobial nightwear with silver marketed by a company which specialises in clothing for people with disabilities

A range of antimicrobial nightwear with silver is being marketed by a company which specialises in clothing for people with physical disabilities.

Manufacturer Allana said the products were made from a luxurious blend of cotton and polyester with Trevira Bioactive silver - which was proven to inhibit the growth of harmful bacteria, including MRSA.

Tiny particles of silver, invisible to the eye, are embedded in the fibres, making the antibacterial effect permanent.

November 13, 2007
There is no single, simple or cheap way to prevent hospital-acquired infections, says a leading microbiologist

There is no single, simple or cheap way to prevent hospital-acquired infections, says a leading microbiologist.

Writing in the Irish Times, Professor Hilary Humphreys, consultant microbiologist at Dublin’s Beaumont Hospital, said hospital infection had become a major issue for Ireland’s health service.

“There is always a potential risk that even the most routine of procedures could result in a complication. No procedure, no drug and no aspect of healthcare is without some risk,” Professor Humphreys said.

October 17, 2007
Specialists are working to prevent an MRSA outbreak at a neonatal unit after six babies tested positive for colonisation

Infection specialists are working to prevent an MRSA outbreak at a neonatal unit after six babies tested positive for colonisation by the resistant pathogen.

The unit, at the Royal Blackburn Hospital in the UK, closed to new admissions last month when the presence of the Panton Valentine leukocidin (PVL) strain of MRSA was identified.

Microbiology laboratories across the UK have been asked to be vigilant and have been requested to send any suspicious samples of PVL for further analysis.

October 2, 2007
Use of antimicrobials containing silver can significantly reduce environmental bacteria levels, trial results suggest

Use of antimicrobials containing silver can significantly reduce environmental bacteria levels, initial trial results suggest.

The study is claimed to be the first-ever trial to investigate the effectiveness of such antimicrobials at reducing environmental bacteria levels.

The trial compared two outpatient wards at the Heart of England NHS Foundation Trust, in the UK's West Midlands.

One ward contained furniture and equipment treated with an antimicrobial protection agent containing silver and one contained untreated items.

June 22, 2007
A novel IT system will coordinate Chlamydia screening in Manchester

Manchester Primary Care Trust in the UK has developed an information technology (IT) system to help with their Chlamydia screening programme.

The Manchester chlamydia programme is one of 16 created after the UK's Department of Health introduced the National Chlamydia Screening Programme in 2002.

The new computerised management and audit system automatically collects and records laboratory data and can handle high volumes of information.

July 1, 2006
RTIs are major global causes of morbidity and mortality, caused by common bacteria and viruses, as well as viruses that can pose pandemic threats. Molecular approaches offer a unique possibility to improve their diagnosis

Peter V Coyle
MD FRC Path
Consultant Virologist/Head of Microbiology
E: peter.coyle@bll.n-i.nhs.uk

Derek Fairley
PhD
Research Scientist
Regional Virus Laboratory
Royal Hospitals Trust
Belfast, UK

July 1, 2006
Rapid and reliable diagnosis of infectious agents is the most important function of a microbiology laboratory. The advantages of molecular approaches based on PCR make them increasingly used as diagnostic tools

Zeynep Ceren Karahan
MD MS
Researcher
Microbiologist

Istar Dolapci
MD PhD
Researcher
School of Medicine Department of Microbiology and Clinical Microbiology
Ankara University Turkey